Complete blood count inflammatory markers (CBC-IMs) have been associated with cardiovascular diseases and mortality. We aimed to evaluate the relationship between preoperative CBC-IMs and 5-year survival after carotid endarterectomy (CEA). Retrospective analysis of 411 consecutive patients who underwent CEA between 2004 and 2018 was done. CBC-IM included the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte (LMR) ratio, and systemic immune-inflammation index (SII). Survival rate at 5 years was 79.8%. Age (hazard ratio (HR) = 1.05, P = .003), hemoglobin (HR = 0.78, P < .001), heart failure (HR = 2.91, P = .005), American Society of Anesthesiologists (ASA)-IV score (HR = 2.41, P = .043), and active neoplastic disease (HR = 2.61, P = .028) were independently related to survival. The discrimination of this model (C-statistic) was 0.698. Spline analysis showed a linear relationship between survival and NLR (P < .001), PLR (P < .001), and SII (P < .001). After adjusting for the baseline predictive score, there was a significant relationship between survival and NLR (HR = 1.191, P = .001), PLR (HR = 1.004, P = .017), and SII (HR = 1.001, P < .001). The addition of NLR, PLR, and SII to the survival model improved the continuous net reclassification index (c-NRI) by 0.29 (P = .028), 0.347 (P = .008), and 0.481 (P < .001), respectively, but not the C-statistic. CBC-IMs show a linear and independent relationship with 5-year survival after CEA and may moderately contribute to patient selection for this preventive intervention.
OddoneEWatersK. Endarterectomy for asymptomatic carotid artery stenosis. JAMA1995; 274(19): 1506.
2.
HallidayAHarrisonMHayterE, et al.10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet2010; 376(9746): 1074–1084.
NaylorARRiccoJBde BorstGJ, et al.Editor's choice-management of atherosclerotic carotid and vertebral artery disease: 2017 clinical practice guidelines of the European Societyfor Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg2018; 55(1): 3–81.
5.
ConradMFKangJMukhopadhyayS, et al.A risk prediction model for determining appropriateness of CEA in patients with asymptomatic carotid artery stenosis. Ann Surg2013; 258(4): 534–538.
6.
WallaertJBCronenwettJLBertgesDJ, et al.Optimal selection of asymptomatic patients for carotid endarterectomy based on predicted 5-year survival. J Vasc Surg2013; 58(1): 112–118.
7.
CarmoMBarbettaIBissaccoD, et al.Development and validation of a score to predict life expectancy after carotid endarterectomy in asymptomatic patients. J Vasc Surg2018; 67(1): 175–182.
8.
KeyhaniSMaddenEChengEM, et al.Risk prediction tools to improve patient selection for carotid endarterectomy among patients with asymptomatic carotid stenosis. JAMA Surg2019; 154(4): 336–344.
9.
MoonGNohHChoIJ, et al.Prediction of late recurrence in patients with breast cancer: elevated neutrophil to lymphocyte ratio (NLR) at 5 years after diagnosis and late recurrence. Breast Cancer2020; 27(1): 54–61.
10.
GuoJFangJHuangX, et al.Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: a meta-analysis of results from multivariate analysis. Int J Surg2018; 60: 216–223.
11.
ZhouXDuYHuangZ, et al.Prognostic value of PLR in various cancers: a meta-analysis. PLoS One2014; 9(6): e101119.
12.
TomitaMAyabeTMaedaR, et al.Systemic immune-inflammation index predicts survival of patients after curative resection for non-small cell lung cancer. Vivo2018; 32(3): 663–667.
13.
TanDFuYTongW, et al.Prognostic significance of lymphocyte to monocyte ratio in colorectal cancer: a meta-analysis. Int J Surg2018; 55: 128–138.
14.
DentaliFNigroOSquizzatoA, et al.Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: a systematic review and meta-analysis of the literature. Int J Cardiol2018; 266: 31–37.
15.
KurtulAOrnekE. Platelet to lymphocyte ratio in cardiovascular diseases: a systematic review. Angiology2019; 70(9): 802–818.
16.
XiangFChenRCaoX, et al.Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: A prospective cohort study. Hemodial Int2018; 22(1): 82–92.
17.
CorriereTDi MarcaSCataudellaE, et al.Neutrophil-to-Lymphocyte Ratio is a strong predictor of atherosclerotic carotid plaques in older adults. Nutr Metab Cardiovasc Dis2018; 28(1): 23–27.
18.
LiuYDuXChenJ, et al.Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect2020; 81(1): e6–e12.
19.
YoldasHKaragozIOgunMN, et al.Novel mortality markers for critically ill patients. J Intensive Care Med2020; 35(4): 383–385.
20.
PengYHuangWShiZ, et al.Positive association between systemic immune-inflammatory index and mortality of cardiogenic shock. Clin Chim Acta2020; 511: 97–103.
21.
HajibandehSHajibandehSHobbsN, et al.Neutrophil-to-lymphocyte ratio predicts acute appendicitis and distinguishes between complicated and uncomplicated appendicitis: a systematic review and meta-analysis. Am J Surg2020; 219(1): 154–163.
22.
HabibMThawabiMHawatmehA, et al.Value of neutrophil to lymphocyte ratio as a predictor of mortality in patients undergoing aortic valve replacement. Cardiovasc Diagn Ther2018; 8(2): 164–172.
23.
AydinOPehlivaniF. Is the platelet to lymphocyte ratio a potential biomarker for predicting mortality in peptic ulcer perforation?Surg Infect2019; 20(4): 326–331.
24.
JomrichGGruberESWinklerD, et al.Systemic Immune-Inflammation Index (SII) predicts poor survival in pancreatic cancer patients undergoing resection. J Gastrointest Surg2020; 24(3): 610–618.
25.
BhuttaHAghaRWongJ, et al.Neutrophil – lymphocyte ratio predicts medium-term survival following elective major vascular surgery: a cross-sectional study. Vasc Endovascular Surg2011; 45(3): 227–231.
26.
DemiraǧMKBedirA. Evaluation of preoperative neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients undergoing major vascular surgery. Turkish J Thorac Cardiovasc Surg2013; 21(4): 930–935.
27.
SegelGBHaltermanMWLichtmanMA. The paradox of the neutrophil’s role in tissue injury. J Leukoc Biol2011; 89(3): 359–372.
28.
NasrNRuidavetsJBArnalJF, et al.Association of neutrophil count with microembolization in patients with symptomatic carotid artery stenosis. Atherosclerosis2009; 207(2): 519–523.
29.
TaşoǧluISertDColakN, et al.Neutrophil-lymphocyte ratio and the platelet-lymphocyte ratio predict the limb survival in critical limb ischemia. Clin Appl Thromb Hemost2014; 20(6): 645–650.
30.
ThaulowEErikssenJSandvikL, et al.Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation1991; 84(2): 613–617.
31.
RoblessPAOkonkoDLintottP, et al.Increased platelet aggregation and activation in peripheral arterial disease. Eur J Vasc Endovasc Surg2003; 25(1): 16–22.
32.
NúñezJSanchisJBodíV, et al.Relationship between low lymphocyte count and major cardiac events in patients with acute chest pain, a non-diagnostic electrocardiogram and normal troponin levels. Atherosclerosis2009; 206(1): 251–257.
33.
ParkBJShimJYLeeHR, et al.Relationship of neutrophil-lymphocyte ratio with arterial stiffness and coronary calcium score. Clin Chim Acta2011; 412(11–12): 925–929.
34.
BressiEMangiacapraFRicottiniE, et al.Impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on 5-year clinical outcomes of patients with stable coronary artery disease undergoing elective percutaneous coronary intervention. J Cardiovasc Transl Res2018; 11(6): 517–523.
35.
ZhangJRenQSongY, et al.Prognostic role of neutrophil-lymphocyte ratio in patients with acute ischemic stroke. Medicine2017; 96(45): e8624.
36.
TokgozSKayrakMAkpinarZ, et al.Neutrophil lymphocyte ratio as a predictor of stroke. J Stroke Cerebrovasc Dis2013; 22(7): 1169–1174.
37.
MassiotNLareyreFVoury-PonsA, et al.High neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with symptomatic internal carotid artery stenosis. J Stroke Cerebrovasc Dis2019; 28(1): 76–83.
38.
SparkJISarveswaranJBlestN, et al.An elevated neutrophil-lymphocyte ratio independently predicts mortality in chronic critical limb ischemia. J Vasc Surg2010; 52(3): 632–636.
39.
DongCHWangZMChenSY. Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: a systematic review and meta-analysis. Clin Biochem2018; 52: 131–136.
40.
VarimCVarimPAcarBA, et al.Usefulness of the platelet-to-lymphocyte ratio in predicting the severity of carotid artery stenosis in patients undergoing carotid angiography. Kaohsiung J Med Sci2016; 32(2): 86–90.
41.
DeşerSBYucelSMDemiragMK, et al.The association between platelet/lymphocyte ratio, neutrophil/lymphocyte ratio, and carotid artery stenosis and stroke following carotid endarterectomy. Vascular2019; 27(6): 604–611.
42.
ZuoBZhuSMengX, et al.Monocyte/lymphocyte ratio is associated with carotid stenosis in ischemic stroke: a retrospective analysis. Brain Behav2019; 9(10): e01429.
43.
GaryTPichlerMBelajK, et al.Lymphocyte-to-monocyte ratio: a novel marker for critical limb ischemia in PAOD patients. Int J Clin Pract2014; 68(12): 1483–1487.
44.
HouDWangCLuoY, et al.Systemic immune-inflammation index (SII) but not platelet-albumin-bilirubin (PALBI) grade is associated with severity of acute ischemic stroke (AIS). Int J Neurosci2021; 131: 1203–1208.
